Clinical Trials Browser

Phase 2 × Thrombocytopenia × Stem Cell Transplantation × Clear all

NCT03303950 2022-05-05

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

Phase 2 Terminated

6 enrolled 17 charts

Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Thrombocytopenia, Primary Myelofibrosis